trevicta 525 mg/2.625 ml suspenzija za injekciju s produženim oslobađanjem
inpharm co. d.o.o. banja luka - палиперидон - suspenzija za injekciju s produženim oslobađanjem - 525 mg/2.625 ml - 2,625 ml suspenzije za injekciju sa produženim oslobađanjem sadrži: 525 mg paliperidona (u obliku paliperidonpalmitata)
prezista
janssen-cilag international nv - danmavir - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adult and paediatric patients from the age of 3 years and at least 15 kg body weight. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). in deciding to initiate treatment with prezista co administered with cobicistat or low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista 75 mg, 150 mg, and 600 mg tablets may be used to provide suitable dose regimens:for the treatment of hiv 1 infection in antiretroviral treatment (art) experienced adult patients, including those that have been highly pre treated. for the treatment of hiv 1 infection in paediatric patients from the age of 3 years and at least 15 kg body weight. in deciding to initiate treatment with prezista co administered with low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). prezista 400 mg and 800 mg tablets may be used to provide suitable dose regimens for the treatment of hiv 1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are:antiretroviral therapy (art) naïve. art experienced with no darunavir resistance associated mutations (drv rams) and who have plasma hiv 1 rna < 100,000 copies/ml and cd4+ cell count ≥ 100 cells x 106/l. in deciding to initiate treatment with prezista in such art experienced patients, genotypic testing should guide the use of prezista.
ponvory
janssen-cilag international n.v. - ponesimod - multipla skleroza, Рецидивно-Ремиттирующее - imunosupresivi - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.
imodium 2 mg raspadljive tablete za usta
mcneil healthcare (ireland) limited, tallaght, high street, office 5, 6 & 7, block 5, dublin, irska - loperamidklorid - raspadljiva tableta za usta - 2 mg - urbroj: jedna raspadljiva tableta za usta sadrži 2 mg loperamidklorida
imodium combo 2 mg/125 mg tablete
mcneil healthcare (ireland) limited, tallaght, high street, office 5, 6 & 7, block 5, dublin, irska - loperamidklorid simetikon - tableta - 2 mg + 125 mg - urbroj: jedna tableta sadrži 2 mg loperamidklorida i 125 mg dimetikona kao simetikon
regaine 50 mg/g pjena za kožu vlasišta
mcneil healthcare (ireland) limited, tallaght, high street, office 5, 6 & 7, block 5, dublin, irska - minoksidil - pjena za kožu - 50 mg/g - urbroj: 1 g pjene za kožu sadrži 50 mg minoksidila (5% w/w)
tremfya 100mg/ml rastvor za injekciju u napunjenom injekcionom špricu
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - guselkumab - rastvor za injekciju u napunjenom injekcionom špricu - 100mg/ml
rezolsta 800mg + 150mg film tableta
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - darunavir, kobicistat - film tableta - 800mg + 150mg
imbruvica 140mg kapsula, tvrda
druŠtvo sa ograniČenom odgovornoŠĆu "inpharm co" podgorica - ibrutinib - kapsula, tvrda - 140mg
erleada 60mg film tableta
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - apalutamid - film tableta - 60mg